Redefining Diabetes Care: IACS Injections and Blood Sugar Management
Insights from a Mayo Clinic Study on IACS Injections and Diabetes Risk
Topline:
A groundbreaking study by the Mayo Clinic reveals that intra-articular corticosteroid (IACS) injections, while temporarily raising blood sugar levels, generally do not exacerbate diabetes progression. This finding is crucial for both patients and healthcare providers to manage the delicate balance between arthritis treatment and glycemic control.
